Relentless Zymeworks stock eyes a breakout from channel. Buyers should keep watch

Zymeworks Inc. (NYSE:ZYME) could be one of the best biotech stocks to buy in November. The stock, which has crashed by 55.71% year-to-date, trades within narrow ranges, but the upside potential is gro...